Directed Discovery of Agents Targeting the Met Tyrosine Kinase Domain by Virtual Screening
- 15 January 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (4), 943-951
- https://doi.org/10.1021/jm800791f
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibProceedings of the National Academy of Sciences, 2007
- Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer ProgressionCancer Research, 2007
- FGFR1 amplification in breast carcinomas: a chromogenic in situhybridisation analysisBreast Cancer Research, 2007
- BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinitiesNucleic Acids Research, 2006
- Virtual screening of chemical librariesNature, 2004
- The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variantsOncogene, 2004
- Crystal Structure of Bisphosphorylated IGF-1 Receptor KinaseStructure, 2001
- ATP site-directed competitive and irreversible inhibitors of protein kinasesMedicinal Research Reviews, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Automatic generation of 3D-atomic coordinates for organic moleculesTetrahedron Computer Methodology, 1990